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ABSTRACT 
ZEBRAFISH AND CONDITIONED PLACE PREFERENCE:  
A TRANSLATIONAL MODEL OF DRUG REWARD 
by Adam Douglas Collier 
August 2015 
Addiction and substance abuse commonly lead to negative outcomes such as 
damaged health, domestic violence, child abuse, failure in school, and loss of 
employment.  In the United States, hundreds of billions of dollars accrue annually in 
costs associated with healthcare, crime and lost productivity due to addiction.  
Efficacious treatments remain few in number, the development of which will be 
facilitated by comprehension of environmental, genetic, pharmacological, and 
neurobiological mechanisms implicated in the pathogenesis of addiction.  The zebrafish 
(Danio rerio) has recently gained popularity as a model organism of complex brain 
disorders (e.g., substance use disorder).  Behavioral quantification within the conditioned 
place preference (CPP) paradigm serves as a measure of the rewarding qualities of a 
given stimulus (e.g., drug).  If animals develop an increase in preference to spend time in 
an environment that had previously been paired with drug administration, the drug is 
inferred to have rewarding properties.  This project reports the effects of acute (1 day) 
and chronic (7 days) exposure to alcohol, caffeine, and nicotine on zebrafish CPP 
behavior.   
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CHAPTER I 
INTRODUCTION 
Substance abuse and addiction are complex and ubiquitous problems; they not 
only negatively affect individuals, but are a tremendous burden to the global economy as 
well.  Alcohol, nicotine, and caffeine are three substances with widespread availability 
throughout much of the world, and are thus commonly used by many people.  Alcohol is 
a particularly devastating substance. The consumption of alcoholic beverages is the third 
largest risk factor for disease in the world, and is responsible for roughly 2.5 million 
deaths each year (World Health Organization, 2011).  Worldwide, the annual 
consumption of alcohol is estimated to be eight times higher than the annual prevalence 
of illicit drug use (United Nations Office on Drugs and Crime, 2012).  Tobacco use is the 
number one preventable cause of mortality and morbidity in the United States, and is 
responsible for about 1 in every 5 deaths (National Institute on Drug Abuse, 2014).  
Nicotine, an addictive psychoactive alkaloid found in the tobacco plant, is responsible for 
higher rates of dependence than any other substance of abuse (Centers for Disease 
Control, 2015).  The use of caffeine, a less harmful substance, is not described as having 
potential to result in a clinically significant use disorder according to the DSM-V.  
However, caffeine is the most commonly used drug in the world (Winston, 2005) with 
over 85% of children and adults consuming it regularly, more than 70% of which 
experience at least one withdrawal symptom following cessation of use (American 
Psychiatric Association, 2013).   
The development of novel pharmacotherapies and targeted intervention strategies 
will be facilitated by comprehension of the various mechanisms (e.g., environmental, 
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genetic, pharmacological and neurobiological) implicated in the pathogenesis of 
addiction.  Animal models have often been utilized to help elucidate such mechanisms 
and processes, most notably those associated with the experience of reward.  Animal 
survival is often dependent upon learning the conditions necessary to acquire naturally 
rewarding and reinforcing stimuli that serve homeostatic and reproductive purposes 
(Hyman, Malenka, & Nestler, 2006).  Animals rapidly learn the behavioral responses 
necessary to obtain natural rewards (e.g., mating opportunities, food and water) and the 
environmental cues that predict them (Bell, Meerts, & Sisk, 2010; Lau, Bretaud, Huang, 
Lin, & Guo, 2006).   
Comparable learning also occurs following consumption of psychoactive 
substances (Everitt, Dickinson, & Robbins, 2001; Hyman et al., 2006).  Rapid 
conditioning often takes place when drug use is paired with an environment, object, or 
emotional state, primarily due to the integrated nature of the brain’s reward circuitry with 
the memory, motivational, and emotional centers of the limbic system (McLellan, Lewis, 
O’Brien, & Kleber, 2000).  Exposure to a stimulus (e.g., environmental) may induce 
craving for the drug in individuals that are dependent on a substance, and even in those 
who have been abstinent from drug use for a period of time, potentially resulting in 
relapse (Childress et al., 1999).   
Understanding how such factors contribute to drug seeking behaviors may 
facilitate new treatment and prevention strategies.  Rats and mice have been 
conventionally employed in this endeavor, chiefly due to the anatomical, biological, and 
genomic homology between rodents and humans (Lieschke & Currie, 2007).  However, 
rodent models are uneconomical, have challenging husbandry, and are not amenable to 
3 
 
 
 
methods of high-throughput screening.  The zebrafish (Danio rerio) provides an 
opportunity to overcome these limitations. 
The Zebrafish Model 
The zebrafish, belonging to the minnow family, is a small freshwater fish 
geographically native to the shallow flood-plain waters of north-eastern India, 
Bangladesh and Myanmar (Engeszer, Patterson, Rao, & Parichy, 2007; Spence, Gerlach, 
Lawrence, & Smith, 2008).  Reproduction occurs via spawning; about 100 eggs are 
released per mating event onto substrate which are then externally fertilized by a male 
sperm cloud (Ruhl, McRobert, & Currie, 2009).  In laboratory conditions zebrafish will 
spawn every few days throughout the year, most often occurring after dawn.  Zebrafish 
remain transparent through embryonic and larval stages, hatch 2-3 days post-fertilization, 
and inflate their gas bladders around day 5 to begin free swimming (Reed & Jennings, 
2010).  Basic body architecture develops within 24 hours in this species, equivalent to 
about 9 days in the mouse (Lardelli, 2000).   
Furthermore, zebrafish reach sexual maturity and adulthood in about 3 months, 
although the rate of individual development may be influenced by environmental and 
genetic factors (Reed & Jennings, 2010).  The small size of adult zebrafish (4 cm long) 
permits easy handling and the housing of a large number of fish in a small laboratory 
environment (Pan, Chatterjee, & Gerlai, 2012).  The upsurge in popularity of the 
zebrafish model over the past several decades has been profound.  For example, a 
PubMed query with the search term ‘zebrafish’ reveals 86 publications in the year 1993, 
and 926 publications ten years later in 2003, a 10.8 fold increase (Figure 1).  The number 
of mouse publications in the same period experienced a mere 1.6-fold increase.   
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Figure 1. PubMed search results with the search term ‘zebrafish’ 
The capability to observe cell-biological events of early zebrafish development in 
vivo attracted researchers to adopt this species as an embryological model as early as the 
1930s (Lieschke & Currie, 2007).  Throughout the 1980s, new genetic techniques became 
readily available, such as cloning and mutagenesis, which progressed the use of the 
zebrafish as a model to investigate genetic components of vertebrate development 
(Streisinger, Walker, Dower, Knauber, & Singer, 1981; Walker & Streisinger, 1983).  In 
1996, genetic screens identified over 4000 mutations and were published in the journal 
Development (Driever et al., 1996; Haffter et al., 1996).  Recently, sequencing of the 
zebrafish genome has been completed, and ~70% of human genes were found to have at 
least one zebrafish orthologue, with 84% of genes associated with human disease being 
present in zebrafish (Howe et al., 2013).  This model has been regarded to be particularly 
ideal for genetic research due to such translational value, high fecundity, rapid 
development, and amenability to high-throughput screening of genetic mutations and 
small molecules (Lieschke & Currie, 2007). 
A Neurobehavioral Model 
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Zebrafish have recently been adopted as a model to study animal behavior, 
specifically as it relates to the function and dysfunction of the nervous system.  This 
burgeoning field is augmented by the vast data accumulated from the rodent model; 
indeed, many behavioral paradigms utilized in rodent research have been aquatically 
converted to accommodate the zebrafish, including the open field, light-dark, T-maze, 
social preference, and predator avoidance tests (Cachat et al., 2013; Gerlai, Lee, & 
Blaser, 2006; Gould, 2011; Grossman et al., 2010; Kyzar et al., 2012).  Recently, a 
comprehensive glossary consisting of 190 detailed zebrafish behaviors has been 
compiled, satisfying the necessity for consistent and well-defined terminology in the field 
(Kalueff et al., 2013).  Some relatively complex behaviors zebrafish are capable of 
include aggression (Echevarria, Hammack, Jouandot, & Toms, 2010; Gerlai, Lahav, Guo, 
& Rosenthal, 2000), anxiety (Egan et al., 2009; Stewart et al., 2011), learning and 
memory (Colwill, Raymond, Ferreira, & Escudero, 2005; Sison & Gerlai, 2010) and most 
notably, behaviors relevant to addiction (López Patiño, Yu, Yamamoto, & Zhdanova, 
2008; Mathur & Guo, 2010).  These behaviors may be experimentally, genetically and/or 
pharmacologically manipulated at both larval and adult stages of development (Guo, 
2009).   
Although there is morphological disparity between zebrafish and humans, 
comparable features of the central nervous system (CNS) allow for behavioral results to 
be generalized to mammals (Guo, 2009).  The zebrafish CNS contains many of the major 
neurotransmitter systems found in mammals, including GABA, glutamate, dopamine, 
norepinephrine, serotonin, histamine, adenosine and acetylcholine (Panula et al., 2010;  
Maximino et al., 2011).  In humans and rodents, the mesolimbic dopamine system, 
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primarily consisting of projections from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAc), prefrontal cortex (PFC), hippocampus and amygdala, is believed to 
become activated by all drugs of abuse (Koob & Volkow, 2010). Although this 
mesolimbic dopamine system is not conserved among humans and zebrafish, the 
anatomical organization of the nervous system is similar among vertebrates, and the 
lateral and medial pallium, as well as dopaminergic projections to the zebrafish forebrain, 
are believed to be homologous to the associated mesolimbic circuitry in mammals 
(Gould, 2011; Rink & Wullimann, 2002a, 2002b) 
A particularly important brain structure implicated in reward learning is the 
amgydala.  This structure assigns positive or negative value to various stimuli, and 
becomes activated by drugs of abuse as well as drug-associated cues (Carelli, Williams, 
& Hollander, 2003; Paton, Belova, Morrison, & Salzman, 2006).  It has recently been 
discovered that the amygdala is responsible for integrating both motivational and spatial 
information (Peck, Lau, & Salzman, 2013).  In the zebrafish brain, the medial pallium has 
been described as structurally and functionally homologous to the mammalian amygdala.  
Increased neuronal activation, measured by expression of the immediate early gene cfos, 
has been reported in this zebrafish brain structure during both conditioned learning and 
drug seeking behavior (Trotha, Vernier, & Bally-Cuif, 2014).  
In mammals, the hippocampus is largely responsible for spatial memory, and 
although zebrafish lack this region, the lateral pallium is believed to be structurally 
homologous, suggesting a conservation of some cognitive processes (Tropepe & Sive, 
2003).  The lateral pallium has been found to become activated in zebrafish during a 
conditioned learning task (Trotha et al., 2014).  Zebrafish have been found to be capable 
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of completing a variety of cognitive tasks.  For example, following the pairing of a visual 
stimulus (i.e., a red cue card) with a reward (i.e., the sight of a conspecific), it was found 
that zebrafish would eventually approach the cue card in the absence of the rewarding 
stimulus, suggesting that zebrafish are capable of forming CS-US associations (Karnik & 
Gerlai, 2012).  In another study, zebrafish were placed into a tank, half of which was 
colored white and the other half colored black, and upon each entry into the black half of 
the tank a mild shock was applied to the water.  On the following day, zebrafish were 
found to display an increased aversion for the black environment and thus suggesting the 
development of avoidance learning (Manuel et al., 2014) 
As a result of the aforementioned behavioral and CNS similarities, the zebrafish 
has emerged as a promising vertebrate model of a wide range of human domains and 
disorders, including, but not limited to, depression (Ziv et al., 2013), anxiety behavior 
(Stewart et al., 2011), social behavior (Echevarria, Buske, Toms, & Jouandot, 2011; 
Miller & Gerlai, 2011), epilepsy (Wong, et al., 2010), sleep disorders (Zhdanova, 2011), 
and most notably, addiction (Darland & Dowling, 2001; Stewart et al., 2010; Stewart et 
al., 2011).  Drugs of abuse have been observed to induce tolerance, withdrawal, and place 
preference in both larval and adult zebrafish (Canavello et al., 2010; Stewart et al., 2011; 
Tran & Gerlai, 2013).  Adult zebrafish exposed to 0.3% ethanol, diazepam, or morphine 
for 2 weeks and then placed in fresh water to simulate drug withdrawal have been 
reported to display anxiogenic phenotypes and a significant increase in whole-body 
cortisol levels (Cachat et al., 2010).  These results are comparable to the effects of 
withdrawal on rodent measures of behavior and physiology (Almela et al., 2012; Silva & 
Madeira, 2012), indicating good face and construct validity of the zebrafish model 
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(Hyman et al., 2006).  This proposed study will capitalize on the advantageous and 
translational characteristics of the zebrafish model of drug reward, facilitated by a well-
established experimental paradigm for evaluating the rewarding (or aversive) properties 
of drugs.   
Conditioned Place Preference (CPP) 
Since its inception, CPP has been extensively utilized, primarily with rodents, to 
evaluate rewarding effects of psychoactive compounds (Tzschentke, 1998; Tzschentke, 
2007).  The apparatus used in CPP testing can vary in design, but typically consists of a 
conditioning box comprised of two or three distinct environmental compartments 
(Darland et al., 2012; Kily et al., 2008).  In the latter design, a central neutral chamber 
acts as a starting zone and allows passage between conditioning compartments (Darland 
et al., 2012; Lau et al., 2006; Mathur, Berberoglu, & Guo, 2011).  
The CPP procedure is generally comprised of three testing phases that occur on 
consecutive days.  During phase 1 the animal is permitted to explore all compartments of 
the apparatus, and the time spent in each compartment is quantified and used as baseline 
place preference.  In phase 2, animals are sequentially restricted to each compartment for 
a period of time in which they receive either experimental or control treatment.  In phase 
3, the animal is once again allowed access to all compartments and final place preference 
is measured.  CPP behavior is typically evaluated by subtracting phase 1 place preference 
from phase 3 preference (i.e., final place preference – baseline place preference) (Mathur, 
et al., 2011).  This value is used to quantify place preference behavior, and if a significant 
change towards the experimental compartment is observed, CPP is established, and the 
experimental treatment is inferred to be rewarding.  Conditioned place aversion (CPA) is 
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conceptually identical to the CPP test, except in that the experimental treatment exhibits 
aversive, often unpleasant qualities.  If animals avoid the environment in which the 
treatment was administered, CPA learning has occurred (Braida et al., 2007).    
The learning processes necessary to form an association between an 
environmental stimulus and a drug stimulus are likely to follow the principles of classical 
(Pavlovian) conditioning.  The drug acts as an unconditioned stimulus (US), which elicits 
a response (e.g., reward) in animals prior to any learning taking place.  The environment, 
which is normally a neutral stimulus on its own, gains incentive salience and becomes a 
conditioned stimulus (CS) following pairing with the US.  The presence of the CS alone 
elicits a conditioned response of place preference behavior following such pairing. 
However, this response is differential in quality to that of a classically conditioned 
response such as the involuntary reflex of salivation in Pavlov’s studies with dogs.  A 
conditioned response in CPP involves the behavior of approaching the CS and spending 
time there.   
In operant (respondent) conditioning paradigms, as in drug self-administration, a 
common alternative to CPP, the presence of the US (e.g., drug) is dependent upon 
engaging in a behavior, such as lever pressing, and is thus under control of the animal.  
Self-administration of a drug such as cocaine for example, reinforces a voluntary 
behavioral response necessary for drug delivery (Goeders & Guerin, 1996).  In contrast, 
drugs are passively administered by the experimenter in CPP, which is not dependent 
upon an animal behavior.  Therefore, there is no response required from animals to 
receive the US in CPP testing, unlike in self-administration procedures.  Distinct 
neurochemical differences in the mesolimbic dopamine system have been found in 
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animals that have self-administered amphetamine compared to those that received the 
drug passively (Di Ciano, Blaha, & Phillips, 1998).  Thus, CPP differentially assesses 
drug reward and engages distinct neuropharmacological circuitry compared to operant 
procedures such as self-administration (Tzschentke, 1998).  For the purposes of this 
study, the term ‘reward’ will be used throughout the duration of this document and 
inferred to be the primary measure of CPP, rather than ‘reinforcement’.  
An important methodological concern in CPP studies is the whether the apparatus 
is ‘biased’ or ‘unbiased’.  The CPP apparatus may be designed in such a way that animals 
will reliably display place preference for one environment over the other prior to 
conditioning, and is referred to as a biased design (Tzschentke, 2007).  In an unbiased 
design, animals do not display a strong preference for one environment over the other 
before conditioning takes place. The effect of biased and unbiased apparatus design has 
been investigated in ethanol place conditioning in mice (Cunningham, Ferree, & Howard, 
2003).  Both designs were employed, and in each, ethanol was randomly paired with 
environmental stimuli such that animals received ethanol in initially preferred and 
initially non-preferred environments.  CPP was observed with the unbiased apparatus 
regardless of ethanol being paired with the preferred or non-preferred side.  Yet, CPP was 
only observed when ethanol was paired with the non-preferred side with the biased 
apparatus.  Thus, apparatus design is of notable concern when evaluating the rewarding 
or aversive effects of novel compounds.  As a result, the unbiased design has been 
predominately employed and held in higher regard than the biased design (Sanchis-
Segura & Spanagel, 2006).   
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Both designs have been employed in zebrafish CPP literature, although the 
majority of which have been unbiased.  An innate preference bias towards brown CPP 
environments over light environments with two black spots has been observed in 
zebrafish (Kedikian, Faillace, & Bernabeu, 2013; Ninkovic & Bally-Cuif, 2006; Ninkovic 
et al., 2006), and nicotine CPP has been reported using both unbiased and biased designs 
(Kedikian et al., 2013; Kily et al., 2008).  There are several reviews available that 
comprehensively catalogue the CPP literature in detail, including discussion of the 
aforementioned issues pertinent to methodology and design (Schechter & Calcagnetti, 
1998; Tzschentke, 1998; Bardo & Bevins, 2000; Tzschentke, 2007, Collier & Echevarria, 
2013, Collier, Khan, Caramillo, Mohn, & Echevarria, 2014). 
In order for animal CPP studies to have good face validity and to contribute to the 
endeavor of reducing suffering related to pandemic drug abuse, the results must be 
relevant to humans.  Childs & Wit (2009) treated human participants with either d-
amphetamine or placebo within two distinct environments, and found that people 
preferred the place associated with amphetamine treatment.  In another human CPP 
study, the researchers used music as US and utilized several virtual reality environments 
to serve as CS.  Half of the participants were asked to visit a virtual house that played 
consonant music for two minutes, and then visited another virtual house that played static 
noise for two minutes, and the remaining half visited the environments in the reverse 
order.  After conditioning took place the participants were free to spend time in either of 
the two houses, and it was found that subjects displayed CPP towards the house with the 
consonant music (Molet, Billiet, & Bardo, 2013).  Thus, like laboratory animals, humans 
implicitly learn associations between environmental stimuli and direct experience. 
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The degree of reward experienced from a drug experience is suggested to predict 
the potential of that substance to be abused (Haertzen et al., 1983).  CPP has been 
induced in the rodent model by addictive substances frequently abused by humans, 
including d-amphetamine (Yates, Marusich, Gipson, Beckmann, & Bardo, 2012), cocaine 
(Bahi, Kusnecov, & Dreyer, 2008; Russo et al., 2008), diazepam (Papp, Gruca, & 
Willner, 2002), ethanol (Kotlinska, Bochenski, & Danysz, 2011), heroin (Braida, Pozzi, 
Cavallini, & Sala, 2001), ketamine (Li et al., 2008), methamphetamine (Zakharova, 
Leoni, Kichko, & Izenwasser, 2009), morphine (Liang et al., 2006), and nicotine 
(Brielmaier, McDonald, & Smith, 2008).  The literature reveals that CPP has not been 
established with drugs that humans do not typically abuse, such as antidepressants, 
neuroleptics, and antihistamines, which is indicative of construct validity of the CPP 
assay (Papp et al., 2002).   
Comparable to many rodent behavioral paradigms, CPP has recently been adopted 
in zebrafish neurobehavioral research (Darland & Dowling 2001; Ninkovic & Bally-Cuif 
2006; Mathur et al. 2011b; Parmar et al. 2011).  Various drugs have been observed to 
induce CPP behavior in zebrafish, often following a single administration, demonstrating 
the potent rewarding properties of these substances and validating the translational value 
of the zebrafish CPP model of drug reward.  For example, zebrafish have been reported 
to develop CPP towards amphetamine (Ninkovic et al., 2006), cocaine (Darland & 
Dowling, 2001; Darland et al., 2012), ethanol (Mathur, Berberoglu, et al., 2011), 
morphine (Lau et al., 2006), salvinorin A (Braida et al., 2007), and nicotine (Bernabeu, 
Aires, & Behavior, 2013). CPP is a relatively simple and inexpensive experiment, and 
13 
 
 
 
when coupled with the zebrafish model, experimental protocols may be automated with 
multiple fish being simultaneously tested (Mathur et al., 2011).   
The Current Study 
Substance abuse is a significant public health concern with detrimental 
consequences, both domestically and worldwide.  Comprehending the relationship 
between drug exposure and conditioning may facilitate the development of new 
preventative strategies and treatments.  For example, a better understanding of how 
environmental factors contribute to drug seeking behavior and relapse may increase the 
efficacy of cognitive-behavioral models, such as relapse prevention, by identifying high-
risk situations for clients (Larimer, Palmer, & Marlatt, 1999; Marlatt & Donovan, 2005).  
In this endeavor, behavioral research with the zebrafish model and CPP assay may yield 
significant insight into the relationship between drug reward and learning.   
Zebrafish are a relatively new model in the field of behavioral pharmacology.  As 
a result, there is a shortage of associated background literature, especially in comparison 
to the well-established and data abundant rodent model.  Place preference behavior in 
zebrafish has been defined as “the tendency to establish a preferred location in which the 
fish spends more time. Can be induced by drugs, repeated administration of food/food 
odors, social reward, or be based on natural behaviors or preferences” (Kalueff et al., 
2013).  The current study investigated the effects of ethanol, caffeine, and nicotine on 
place preference behavior in zebrafish.  Ethanol and nicotine zebrafish CPP behavior 
have been reported, although only a limited range of doses and durations of exposure 
have been tested (Kedikian et al., 2013; Kily et al., 2008; Mathur, Lau, et al., 2011; 
Parmar, Parmar, & Brennan, 2011).  For example, nicotine CPP has only been 
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investigated following one and three conditioning sessions, and a mere three doses of 
ethanol have been evaluated in the zebrafish CPP literature. Caffeine CPP in zebrafish 
has not been reported at any concentration.  Thus, the caffeine findings in this study are 
novel.   
There is a crucial need for the investigation of a broader range of doses and 
durations of exposure to the aforementioned substances in an effort to better establish the 
zebrafish model of drug reward.  The current study was inspired by this rationale.  
Zebrafish place preference behavior following acute administration (i.e., one conditioning 
session) of four separate doses of ethanol (i.e., 0.00%, 0.25%, 0.50%, and 1.00%), four 
doses of caffeine (i.e., 0 mg/L, 50 mg/L, 100 mg/L and 150 mg/L), and four doses of 
nicotine (i.e., 0 mg/L, 2.5 mg/L, 5 mg/L and 10 mg/L) was evaluated in two experimental 
apparatus designs.  Zebrafish place preference behavior following chronic administration 
(i.e., seven conditioning sessions) of the aforementioned drugs and doses was also 
investigated.  
Hypotheses and Research Question 
Hypotheses 
H1 - It was expected that zebrafish would display CPP behavior in a drug and 
dose and duration (acute vs. chronic) dependent manner, following administration of 
ethanol, caffeine, and nicotine.  
H2 - It was expected that an equal number of zebrafish would display a baseline 
place preference for each environment, of both apparatus designs, and an equal number 
of time would be spent in each environment during baseline place preference testing.  
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H3 – It was expected that conditioning order (i.e., receiving drug first or second) 
would have an effect on place preference behavior.  
Research Question 
The researcher seeks to determine if the zebrafish model organism, coupled with 
the CPP assay, may be employed as an effective and valid model of drug reward.  
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CHAPTER II 
METHODOLOGY 
Subjects and Husbandry 
All fish were maintained and protocols carried out according to the Institutional 
Animal Care and Use Committee of the University of Southern Mississippi, Hattiesburg 
MS, USA.  Adult zebrafish of a randomly bred genetically heterogeneous ‘wildtype’ 
strain were obtained from a local distributor (Pet Palace, Hattiesburg MS 39401).  All 
fish were acclimated to the laboratory environment for a minimum of 10 days, housed 
within a 55 L (76 cm high x 30 cm wide x 25 cm high) group holding tank, and then 
individually and adjacently housed within 2.5 L tanks (20 cm high x 13 cm long x 14 cm 
high) at least 48 hours prior to behavioral testing.  All tanks were maintained in a 
circulating system equipped with biological, chemical, and mechanical filtration, 
aeration, and sterilization by UV light.  Ceiling-mounted fluorescent light tubes provided 
illumination during a 14/10 hour light/dark cycle.  Tank water consisted of reverse 
osmosis deionized H2O supplemented with 60 mg/L dissolved sea salts (Instant Ocean: 
Blacksburg, VA 24060), and was maintained at ~25-27 Cº.  Fish were fed once in the 
morning with brine shrimp (Premium Grade Brine Shrimp Eggs, Brine Shrimp Direct, 
Ogden, UT), and once in the afternoon with flake food (Tetra: Blacksburg, VA).  All 
animals were drug and experimentally naïve prior to testing.  Experimentation took place 
between 9:00 AM and 4:00 PM.  All behavior was recorded by USB webcams (saved as 
MP4 files for subsequent analysis) mounted to an overhead shelter, which also provided 
equal light distribution and prevented fish from observing outside the tank.   
 
  
CPP Apparatus Design 1
The first CPP apparatus 
20 cm wide x 24 cm tall).  
conditioning to prevent cross
and after testing.  The preference testing 
divided it into two distinct halves; one half was colored white, the other was white with a 
fixed pattern of 14 black dots 2.43 cm in diameter (
adopted from previous methods 
Figure 2. CPP apparatus 
Tanks used for drug administration (i.e., conditioning)
with the exception of central divider that was sealed 
transference of water or drug
two dots, for a total of 16 
 
The CPP Apparatus 
 
design consisted of a 30 L glass aquarium (41 cm long x 
Separate aquarium tanks were used for preference testing and 
-contamination, and were rinsed with deionized water before 
tank was colored by adhesive shelf liner that 
Figure 2)  This apparatus
(Mathur et al., 2011)   
 
design 1: Preference testing apparatus  
 were identical in design, 
with aquarium sealant 
 between chambers.  The divider also included an additional 
dots on one side of the conditioning apparatus (
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 design was 
to prevent 
Figure 3).   
  
Figure 3. CPP apparatus design 1: 
CPP Apparatus Design 2
The second CPP apparatus 
aquarium (41 cm long x 20 cm wide x 24 cm tall).  The preference testing 
colored by adhesive shelf liner that divided it into two distinct halves; one half was 
colored white with a fixed pattern of 
pattern of 15 blue rectangles
from black to blue to create better contrast between zebrafish and the background to aid 
in video analyses.  In an effort to reduce potential bia
other, it was decided to design this apparatus with two similar, but distinct environments. 
These environments differed in their pattern shapes and pattern design, and were similar 
in that the shapes were the same color (
Figure 4. CPP apparatus design 2: Preference testing apparatus
 
 
Conditioning apparatus  
 
design also consisted primarily of a 30 L glass 
15 blue dots, the other was white with a f
 (Figure 4). The color of the shape patterns were changed 
s towards one environment over the 
i.e., blue) and of the same quantity.
 
 
18 
tank was 
ixed 
 
  
The second CPP conditioning apparatus differed from the first.  In an effort to 
create a more efficient design and 
experimentation, 500 mL crystallizing dishes colored with adhesive shelf liner were 
employed as conditioning chambers
shapes, of either dots or rectangles
preference testing apparatus. 
Figure 5. CPP apparatus design 2: Conditioning apparatus 
Phase 1: Baseline place preference
During phase 1, on the first day of experimentation for each cohort
carefully transported, while still within their home tanks, from the housing system to 
nearby experimental table.
to acclimate to the new environment.  CPP 
filled with 5 L of system water upon the experimenter’s re
netted from their home tanks and placed directly into the
Home tanks of animals were close in proximity to 
stress and hypoxia.  The experimenter quietly left the room and allowed the zebrafish to 
explore the apparatus for 15 minutes
 
conserve the quantity of drugs used du
 (Figure 5).  Each conditioning dish had a total of 13 
, with patterns that closely mimicked that 
 
 
 
The CPP Procedure 
 
  The experimenter then left and allowed zebrafish 10
preference testing tanks, in both designs,
-entry; fish were then carefully 
 center of the CPP apparatus.  
the CPP tanks to minimize netting 
.  Fish were then returned to their home tank and 
19 
ring 
of the 
, animals were 
the 
 minutes 
 were 
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placed back into the housing system.  The initial 5 minutes of exploration were 
designated for acclimation to the new environment; behavior during this period was not 
included for analyses.   
The duration of time zebrafish spent within each distinct environment was 
manually recorded via visual observation of video playback by multiple observers for the 
remaining 10 minutes of exploration.  Video analyses occurred in a separate room 
adjacent to the experimental environment.  The times spent in each side of the preference 
testing tank were then expressed as percentages of the 10 minute testing period, and 
served as baseline place preference values.  Zebrafish that spent 80% of time or more in 
one environment were excluded from further testing.  Thus, animals that spent between 
50.1% and 79.9% in one environment were included for the remainder of the experiment, 
with this environment being deemed as the preferred side, and the remaining environment 
being labeled as the non-preferred side.  
Phase 2: Conditioning 
Following establishment of baseline place preference, each animal was assigned 
to receive treatment in the non-preferred side.  This assay employed a balanced design, in 
that the order of conditioning was sequenced so that half of the animals were first 
exposed to treatment and then system water, and the other half were first exposed to 
system water and then treatment.  Previous researchers have reported this balanced order 
of conditioning to have no significant effect on place preference behavior (Mathur et al., 
2011).  System water (e.g., 2.5 L in apparatus design 1 and 0.5 L in apparatus design 2) 
was added to each compartment, and appropriate drug concentrations were prepared and 
dissolved into the water.   
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After being transferred and acclimated to the experimental table, fish were netted 
and placed into the applicable conditioning compartment and allowed to swim freely for 
20 minutes.  Animals were then netted and placed in a tank containing 1.5 L system water 
for 1 minute to wash off any externally bound drug.  Lastly, fish were netted and placed 
into the remaining compartment and once again allowed to explore for 20 minutes.  
Animals were then removed from the conditioning apparatus, placed in a 1.5 L tank of 
system water for 5 minutes, and then returned to home tanks and the housing system.  
Zebrafish that were conditioned for one day belonged to the acute treatment group, and 
fish that were conditioned for seven days belonged to the chronic treatment group.  
During conditioning, experimental animals were treated with a dose of either ethanol 
(Decon Laboratories, Inc. King of Prussia, PA 19406), anhydrous caffeine (Fisher 
Scientific, Fair Lawn NJ 07410), or of liquid nicotine (Sigma-Aldrich, St. Louis, MO).  
Control fish always received system water in the same volume as drug additions.    .    
Phase 3: Final Place Preference 
On the final day of testing, fish were evaluated for final preference using identical 
procedures used to determine baseline preference during phase 1.  Change in place 
preference was calculated by subtracting the percentage of time spent in the drug-paired 
environment before conditioning from the percentage of time in the drug-paired 
environment after conditioning, and then expressed as a percentage.      
Statistical Analyses 
CPP data was first assessed to evaluate changes in place preference for the 
treatment side before and after conditioning for each drug, dose, and apparatus design by 
a two-way mixed model ANOVA of drug x time (before conditioning vs. after 
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conditioning).  The accepted level of significance for ANOVA was p < 0.05.  Paired-
samples post hoc t-tests were used to explore the interaction and evaluate significant 
differences between place preference for the drug paired side before and after 
conditioning for each cohort using a Bonferroni adjusted alpha level of p < 0.0125 (i.e., 
05/4).  Changes in place preference towards the drug-paired side were compared between 
groups by a one-way ANOVA, followed by planned comparisons of comparing control to 
the three doses within each drug cohort.  The effect of duration of treatment (i.e., acute 
vs. chronic) was evaluated for each drug and dose tested from apparatus design 2 by a 
factorial between-subjects ANOVA followed by simple effects analyses.  The effect of 
environment on time spent in the preferred side during baseline preference testing was 
assessed using independent measures t-test.  The effect of conditioning order on change 
in preference towards the drug paired side was evaluated with independent measures t-
test.  SPSS version 23 (IBM Corp, Armonk, NY) was used to perform statistical analyses.  
CPP data were expressed as mean (±SEM). 
 
 
 
 
 
 
 
 
 
  
Results revealed a significant main effect of time 
after conditioning) on dose of 
ηp² = .330.  A significant interaction of time and ethanol was not revealed, although this 
value was approaching statistical 
Post-hoc paired samples t tests revealed significant differences in place preference before 
and after conditioning for 0.25%, 0.50% and 1.00% ethanol
ethanol induced CPP behavior 
Table 1).  
Figure 6. Acute ethanol a
treatment side before vs. after c
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CHAPTER III 
RESULTS 
Ethanol CPP Results 
(i.e., before conditioning vs. 
acute ethanol in apparatus 1, F(1, 56) = 27.603, 
significance F(3, 56) = 2.620, ηp² = .123, p = 0.060
, indicating that these doses of 
in zebrafish following a single pairing (see 
pparatus 1 CPP behavior: paired samples analyses of time in 
onditioning data expressed as mean (±SEM).
0.25% 0.50% 1.00%
* 
* 
* 
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p < .001, 
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Figure 6 and 
 
 *p < 0.0125.  
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Table 1 
 
Acute Ethanol Apparatus 1 CPP Behavior: Paired Samples Analyses of Time in Treatment 
Side Before vs. After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0.00% 37.47 9.13 39.93 9.48 15 1.29 0.215 0.28 
0.25% 39.60 5.54 48.13 7.86 15 3.49 0.004* 1.25 
0.50% 34.80 10.56 49.40 14.47 15 2.90 0.011* 1.15 
1.00% 36.20 9.05 53.47 18.46 15 3.06 0.008* 1.88 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .0125 
 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was significantly greater for the group that received acute 0.50% ethanol 
compared to the group that received 0.00% ethanol (i.e., the control group), t(56) = 2.081, 
p = 0.041, d = 0.82 (Figure 7).  The group that received the highest dose of ethanol, 
1.00%, also displayed a significantly greater place preference change towards the drug-
paired environment than the control group, t(56) = 2.543, p = 0.014, d = 0.90.  No 
significant difference between 0.00% ethanol and 0.25% ethanol was revealed.  
  
Figure 7. Acute ethanol apparatus 1 CPP 
towards the drug-paired side. 
 
Results revealed a significant main effect of time on dose of 
apparatus 2, F(1, 38) = 27.55, p <0.001, 
ethanol was not revealed, 
t tests did not reveal any significant differences in place preference before and after 
conditioning for 0.25%, 0.50% and 1.00% ethanol (see 
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difference scores: Change in place preference 
 Data expressed as mean (±SEM). *p < 0.05. **
acute 
ηp 2 = 0.42.  A significant interaction of time and 
F(3, 38) = 1.86, p = 0.153, ηp 2 = 0.13.  Post-hoc paired samples 
Figure 8 and Table 2
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Ethanol concentration in tank water
Apparatus 1
0.25% 0.50% 1.00%
 
25 
 
p < 0.01  
ethanol in 
). 
 
Before
After
26 
 
 
 
Figure 8. Acute ethanol apparatus 2 CPP behavior:  Paired samples analyses of time in 
treatment side before vs. after conditioning data expressed as mean (±SEM).  *p < 0.0125  
 
Table 2 
 
Acute Ethanol Apparatus 2: Paired Samples Analyses of Time in Treatment Side Before vs. 
After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0.00% 42.72 4.96 47.25 10.19 12 1.51 0.159 0.57 
0.25% 40.45 4.99 60.87 22.96 9 2.99 0.014 1.20 
0.50% 41.94 7.45 59.14 15.37 8 2.66 0.033 1.40 
1.00% 40.32 9.86 52.48 15.09 13 2.77 0.017 0.95 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .0125 
 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was significantly greater for the group that received acute 0.25% ethanol 
compared to the group that received 0.00% ethanol (i.e., the control group), t(38) = 2.197, 
p = 0.034, d = 0.94 (Figure 9).  No significant changes in place preference towards the 
ethanol-paired side were found between either acute 0.50% or 1.00% ethanol groups 
when compared to the control group.   
  
Figure 9. Acute ethanol apparatus 2 CPP 
towards the drug-paired side.  
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in apparatus 2, F(1, 25) = 5.766, p = 0.
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difference scores: Change in place preference 
Data expressed as mean (±SEM). *p < 0.05. **
 a significant main effect of time on dose of 
24, ηp 2 = 0.19.  A significant interaction of time 
F(3, 25) = 0.71, p = 0.557, ηp 2 = 0.08.  Post
 any significant differences in place preference before and 
 dose of ethanol (see Figure 10 and Table 3). 
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Figure 10. Chronic ethanol apparatus 2 CPP behavior: Paired samples analyses of time in 
treatment side before vs. after conditioning data expressed as mean (±SEM). *p < 0.0125  
 
Table 3 
 
Chronic Ethanol Apparatus 2: Paired Samples Analyses of Time in Treatment Side Before 
vs. After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0.00%  42.85 6.89 51.66 5.59 8 3.05 0.019 1.40 
0.25% 43.69 3.26 43.90 18.36 8 0.04 0.973 0.02 
0.50% 44.73 6.04 53.89 7.65 7 2.18 0.072 1.33 
1.00% 40.50 6.44 50.58 16.30 6 1.21 0.279 0.81 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .05. **p < .0125 
 
 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was not significantly different for either chronic 0.25%, 0.50%, or 1.00% 
ethanol in apparatus 2 when compared to the change in place preference in control fish 
(Figure 11). 
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Figure 11. Chronic ethanol apparatus 2 CPP 
preference towards the drug
< 0.01  
 
The effect of duration of treatment (i.e., acute vs. chronic) on change in place 
preference towards the ethanol
63) = 3.474, p = 0.067, ηp
place preference towards the drug
chronically with 0.25% ethanol compared to zebrafish treated acutely with 0.25% ethanol 
F(1, 63) = 7.089, p = 0.010, 
(Figure 12).  
Figure 12. Acute vs. chronic ethanol 
(±SEM). *p < 0.05. **p < 0.01 
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difference scores: Change in place 
-paired side. Data expressed as mean (±SEM). *
 paired side was found to be marginally significant, 
 2
 = 0.052.  An analysis of simple effects showed that change
-paired side was significantly less for zebrafish treated 
ηp 2 = 0.10. No other significant effects were revealed 
CPP difference scores: Data expressed as mean 
 
Caffeine CPP Results 
(i.e., before conditioning vs. 
acute caffeine in apparatus 1, F(1, 59) = 14.72, p < 0.001, , 
caffeine was not revealed, 
-hoc paired samples t tests did not reveal any
0.25% 0.50% 1.00%
Scores: Apparatus 2
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differences in place preference before and after conditioning for any dose of caffeine (see 
Figure 13 and Table 4).  
 
Figure 13. Acute caffeine apparatus 1 CPP behavior:  Paired samples analyses of time in 
treatment side before vs. after conditioning data expressed as mean (±SEM). *p < 0.0125  
 
Table 4 
 
Acute Caffeine Apparatus 1: Paired Samples Analyses of Time in Treatment Side Before 
vs. After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0 mg/L 39.27 6.73 43.47 11.87 15 1.39 0.184 0.44 
50 mg/L 39.06 7.99 45.82 13.96 17 1.63 0.122 0.59 
100 mg/L 37.31 2.24 45.63 10.85 16 2.19 0.044 0.84 
150 mg/L 37.47 2.13 46.80 12.93 15 2.52 0.024 0.86 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .0125 
 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was not significantly different for either acute 50 mg/L, 100 mg/L or 150 
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mg/L of caffeine in apparatus 1 when compared to the change in place preference in 
control fish (Figure 14). 
 
Figure 14. Acute caffeine apparatus 1 CPP difference scores: Change in place preference 
towards the drug-paired side.  Data expressed as mean (±SEM). *p < 0.05. **p < 0.01  
 
Results did not reveal a significant main effect of time (i.e., before conditioning 
vs. after conditioning) on dose of acute caffeine in apparatus 2, F(1, 29) = 3.98, p = 
0.055, ηp 2 = 0.12.  A significant interaction of time and caffeine was not revealed, F(3, 
29) = 0.043, p = 0.99, ηp 2 = 0.004.  Post-hoc paired samples t tests did not reveal 
significant differences in place preference before and after conditioning for zebrafish 
treated acutely with either 0 mg/L, 50 mg/L, 100 mg/L or 150 mg/L of caffeine (see 
Figure 15 and Table 5).  
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Figure 15. Acute caffeine apparatus 2 CPP behavior:  Paired samples analyses of time in 
treatment side before vs. after conditioning data expressed as mean (±SEM). *p < 0.0125  
 
Table 5 
 
Acute Caffeine Apparatus 2: Paired Samples Analyses of Time in Treatment Side Before 
vs. After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0 mg/L 46.01 4.39 51.78 8.8 8 1.59 0.155 0.83 
50 mg/L 46.12 3.13 50.31 13.72 9 0.89 0.430 0.42 
100 
mg/L 
41.58 8.49 48.50 12.92 8 0.94 0.378 0.63 
150 
mg/L 
43.13 6.12 48.36 14.88 8 0.94 0.379 0.46 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .05. **p < .0125 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was not significantly different for either acute 50 mg/L, 100 mg/L or 150 
mg/L of caffeine in apparatus 2 when compared to the change in place preference in 
control fish (Figure 16). 
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Figure 16. Acute caffeine apparatus 1 CPP difference scores: Change in place preference 
towards the drug-paired side. Data expressed as mean (±SEM). *p < 0.05. **p < 0.01  
 
Results revealed a significant main effect of time (i.e., before conditioning vs. 
after conditioning) on dose of acute caffeine in apparatus 2, F(1, 27) = 27.44, p < 0.001, 
ηp 2 = 0.50.  A significant interaction of time and caffeine was not revealed, F(3, 27) = 
1.12, p = 0.359, ηp 2 = 0.11.  Post-hoc paired samples t tests revealed a significant 
difference in place preference for zebrafish chronically treated with 50 mg/L, indicating 
that these doses induced CPP behavior (see Figure 17 and Table 6).  
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Figure 17: Chronic caffeine
in treatment side before vs. after conditioning.  D
0.0125  
 
Table 6 
 
Chronic Caffeine Apparatus 2: Paired Samples Analyses of Time in Treatment Side Before 
vs. After Conditioning 
 
  
 Before 
   
Dose M SD
0 mg/L 42.85 6.89
50 mg/L 44.26 5.04
100 mg/L 40.46 8.87
150 mg/L 33.86 12.06
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125. 
*p < .0125 
 
Planned contrasts revealed that the change in place preference towards the drug
paired side was not significantly different for chronic administration of either 50 mg/L, 
100 mg/L or 150 mg/L of caffeine in apparatus 2 when compared to the change in place 
preference in control fish (F
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 apparatus 2 CPP behavior:  Paired samples analyses of time 
ata expressed as mean (±SEM). 
   
After   
    
 M SD n t 
 51.66 5.59 8 3.05 
 58.88 12.42 8 3.52 0.010
 48.05 7.7 8 2.56 
 47.97 9.05 7 2.24 
 
igure 18). 
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0.019 1.40 
* 1.54 
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0.066 1.32 
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Figure 18. Chronic caffeine apparatus 2 difference scores: Change in place preference 
towards the drug-paired side.  Data expressed as mean (±SEM). *p < 0.05. **p < 0.01  
 
The effect of duration of treatment (i.e., acute vs. chronic) on change in place 
preference towards the caffeine paired side was not found to be significant, F(1, 56) = 
2.189, p = 0.145, ηp 2 = 0.04 (Figure 19).  An analysis of simple effects showed that 
change in place preference towards the drug-paired side was not significantly different 
for any dose comparison across duration of treatment.  
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Figure 19. Acute vs. chronic 
(±SEM). *p < 0.05. **p < 0.01 
 
Results revealed a significant main effect of time 
after conditioning) on dose of 
ηp 2 = 0.40.  A significant interaction of time and 
F(3, 26) = 1.43, p = 0.26,
significant difference in place preference before and after conditioning for zebrafish 
treated acutely with 0 mg/L nicotine, 
20 and Table 7).  
 
Figure 20. Acute nicotine apparatus 2 CPP behavior:  Paired samples analyses of time in 
treatment side before vs. after conditioning d
 
Table 7 
 
Acute Nicotine Apparatus 2: Paired Samples 
vs. After Conditioning 
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caffeine CPP difference scores: Data expressed as mean 
 
Nicotine CPP Results 
(i.e., before conditioning vs. 
acute nicotine in apparatus 2, F(1, 26) = 17.13, p < 0.001,
nicotine was not revealed, 
 ηp 2 = 0.14.  Post-hoc paired samples t tests revealed a 
but not for any other doses of nicotine 
ata expressed as mean (±SEM). 
Analyses of Time in Treatment Side Before 
   
2.5 mg/L 5 mg/L 10 mg/L
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 Before After     
         
Dose M SD M SD n t p d 
0 mg/L 43.03 5.09 46.70 6.33 7 3.78 0.009* 0.64 
2.5 mg/L 40.29 8.93 47.52 5.42 8 2.18 0.066 0.98 
5 mg/L 43.05 5.55 52.11 6.03 8 2.91 0.023 1.56 
10 mg/L 44.31 3.15 46.43 6.85 7 1.02 0.346 0.40 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .0125 
 
Planned contrasts revealed that the change in place preference towards the drug-
paired side was not significantly different for acute administration of either 2.5 mg/L, 5 
mg/L, or 10 mg/L of nicotine in apparatus 2 when compared to the change in place 
preference in control fish (Figure 21). 
 
Figure 21. Acute ethanol apparatus 1 CPP difference scores: Change in place preference 
towards the drug-paired side.  Data expressed as mean (±SEM). *p < 0.05. **p < 0.01  
 
Results revealed a significant main effect of time (i.e., before conditioning vs. 
after conditioning) on dose of chronic nicotine in apparatus 2, F(1, 24) = 28.47, p < 
0.001, ηp 2 = 0.54.  A significant interaction of time and nicotine was not revealed, F(3, 
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24) = 1.22, p = 0.324, ηp 2 = 0.13.  Post-hoc paired samples t tests revealed no significant 
differences in place preference before and after conditioning for zebrafish treated 
chronically with 0 mg/L, 2.5 mg/L and 10 mg/L of nicotine (see Figure 22 and Table 8).  
 
Figure 22. Chronic nicotine apparatus 2 CPP behavior:  Paired samples analyses of time 
in treatment side before vs. after conditioning data expressed as mean (±SEM). *p < 
0.0125  
 
Table 8 
 
Chronic Nicotine Apparatus 2: Paired Samples Analyses of Time in Treatment Side Before 
vs. After Conditioning 
 
       
 Before After     
         
Dose M SD M SD n t p d 
0 mg/L 42.85 6.89 51.66 5.59 8 3.05 0.019 1.40 
2.5 mg/L 42.83 2.94 51.45 7.41 8 2.70 0.031 1.53 
5 mg/L 42.60 5.95 46.59 8.39 7 1.52 0.179 0.55 
10 mg/L 44.60 2.99 56.62 8.94 5 4.24 0.013 1.80 
 
Note. Statistical significance was determined by a Bonferroni adjusted alpha level of .05/4 = 0.0125.  
*p < .0125 
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Planned contrasts revealed that the change in place preference towards the drug-
paired side was not significantly different for chronic administration of either 2.5 mg/L, 5 
mg/L, or 10 mg/L of nicotine in apparatus 2 when compared to the change in place 
preference in control fish (Figure 23). 
 
Figure 23. Chronic nicotine apparatus 2 CPP difference scores: Change in place 
preference towards the drug-paired side.  Data expressed as mean (±SEM). *p < 0.05. 
**p < 0.01  
 
The effect of duration of treatment (i.e., acute vs. chronic) on change in place 
preference towards the nicotine-paired side was not found to be significant, F(1, 50) = 
1.282, p = 0.263, ηp 2 = 0.03 (Figure 24).  An analysis of simple effects showed that 
change in place preference towards the drug-paired side was significantly greater for 
zebrafish treated chronically with 10 mg/L of nicotine compared to zebrafish treated 
acutely with 10 mg/L of nicotine F(1, 50) = 5.205, p = 0.027, ηp 2 = 0.094.   
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Figure 26. Initial time spent in preferred sides of the CPP apparatus 1 during baseline 
testing.  Data expressed as mean (±SEM). *p < 0.05. **p < 0.01  
 
In apparatus design 2, more fish displayed a baseline preference towards the 
dotted side (n = 110) than the rectangle side (n = 83).  A binomial test indicated that the 
proportion of zebrafish who preferred the dotted side of 57% was not significantly higher 
than the hypothesized proportion of 50%, p = 0.061 (Figure 27).       
 
Figure 27. Initial time in preferred sides of the CPP apparatus 2.  Data expressed as mean 
(±SEM). *p < 0.05. **p < 0.01  
 
An independent samples t-test revealed that there was no significant effect of the 
side zebrafish preferred during baseline testing on the time spent in that side in apparatus 
design 2 (p = 0.617).  Animals that initially preferred the dotted side during baseline 
testing spent about the same amount of time in that side, as did animals that initially 
preferred the rectangle side (Figure 28) 
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Figure 28. Initial time in preferred sides of the CPP apparatus 2.  Data expressed as mean 
(±SEM). *p < 0.05. **p < 0.01  
 
The effect of conditioning order on change in place preference towards the drug 
paired side was also assessed (Figure 29).  Zebrafish that were first placed in their 
preferred side and administered only water, and then placed in their non-preferred side 
and administered drug, displayed a significantly greater change in place preference 
towards the drug paired side than fish that were first placed in their non-preferred side 
and received drug, and then placed in their preferred side and received water, t(191) = 
3.21, p = 0.002, d = 0.46 (Figure 29).  To summarize this effect, zebrafish that received 
drug second during conditioning displayed a greater change in place preference than 
zebrafish that received drug first.  
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CHAPTER IV 
DISCUSSION 
The rewarding effects of ethanol, caffeine and nicotine were assessed in this study 
by evaluating the ability of these substances to increase place preference for an 
environment that was not initially preferred by zebrafish.  Behavioral paradigms 
historically tested in rodents, such as CPP, have only recently been applied in zebrafish 
neurobehavioral research (Darland & Dowling, 2001).  Therefore, concerted efforts at 
replication of previously reported findings, in addition to assessing novel and untested 
compounds and doses, will help establish good face validity of the zebrafish CPP model.  
The advantageous characteristics of the zebrafish, when coupled with a relatively simple 
CPP procedure that can be carried out in a short period of time with multiple animals 
being tested simultaneously, establish this model as a reliable and effective model of drug 
reward.  Although the zebrafish brain and behavior are not homologous to that of 
mammals, anatomical organization and the biology of the nervous system are generally 
conserved among vertebrates, mediating many of the same behaviors.   
These results demonstrate that ethanol is capable of inducing CPP in adult 
zebrafish following a single (i.e., acute) 20 minute administration with concentrations of 
0.25%, 0.50% and 1.00% v/v in apparatus design 1, similar to previously published 
findings (Kily et al., 2008; Parmar et al., 2011), with the exception of the 0.50% 
concentration, which is being reported for here the first time.  However, these doses of 
acute ethanol were not found to induce CPP behavior in zebrafish in apparatus design 2.    
Results also indicated that change in place preference towards the ethanol-paired side was 
significantly greater following acute 0.50% and 1.00% ethanol compared to control in 
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apparatus design 1, but not following acute 0.25%.  In apparatus design 2, change in 
place preference towards the ethanol-paired side was greater following acute 0.25% 
ethanol, but not 0.50% or 1.00% ethanol when compared to control. These differential 
results following acute ethanol treatment between apparatus designs may be attributable 
to overall lower sample sizes in apparatus 2.  It is also possible that these differences are 
due to the nature of the environmental stimuli used in each apparatus design.  For 
example, zebrafish may have been better able to differentiate between the two 
environments in apparatus 1 (i.e., white vs. black dots) than in apparatus 2 (i.e., blue dots 
vs. blue rectangles). Although a baseline bias for the white environment was found in 
apparatus design 1, the high degree of visual distinction between environments may be 
necessary for animals to develop a conditioned association. Future investigation into the 
ability of zebrafish to differentiate between various environmental stimuli and the testing 
of other apparatus designs is warranted.      
Ethanol has been reported to produce a linear-like relationship of dose-dependent 
increases in dopamine production following a 1 hour exposure to the same concentrations 
tested in the present experiment, 0.00%, 0.25%, 0.50%, and 1.00% v/v ethanol 
(Chatterjee & Gerlai, 2009).  Although direct experimental evidence is needed, it appears 
that dopamine may play a role in the ability of acute alcohol to produce CPP in zebrafish. 
In a previous study from our laboratory, blood alcohol concentrations (BAC) were 
measured in zebrafish following a 10 minute immersion in 0.125%, 0.25%, 0.50% and 
1.00% v/v ethanol.  The first three doses produced a relatively linear increase in blood 
alcohol levels (0.050%, 0.058%, and 0.065% respectively), and 1.00% resulted in BAC 
of ~0.10%, verifying the absorption of ethanol through immersion in a bath solution 
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(Echevarria et al., 2010).  Thus, the linear-like changes in place preference that were 
observed following acute ethanol exposure in apparatus 1 are more closely related to the 
aforementioned biological data than acute ethanol results from apparatus 2, providing 
further support that the distinctive nature of apparatus design 1 may more appropriate for 
CPP testing in zebrafish.  
Additionally, the effects of chronic administration of ethanol on place preference 
behavior was investigated in the present study and it was found that no dose of ethanol 
significantly increased time spent in the non-preferred environment. Moreover, no 
changes in place preference between-groups were found to be significant. Compared to 
acute ethanol treatment, change in place preference following chronic 0.25% ethanol was 
found to be significantly less than acute 0.25% ethanol, but no other differences in this 
regard were revealed. There was a relatively high amount of variation between zebrafish 
chronically treated with 0.25% ethanol (i.e., SD = 18.36), especially when compared to 
zebrafish acutely treated with 0.25% ethanol (i.e., SD = 7.86).  A larger sample size may 
have mitigated this high degree of variation in zebrafish chronically treated with 0.25% 
ethanol, potentially influencing the aforementioned difference.  
Furthermore, the results from chronic ethanol exposure in this study do not 
conform well to previously reported findings in the zebrafish literature.  For example, it 
has been reported that both acute and chronic administration of 0.25% and 1.00% ethanol 
in a CPP task induced significant place preference behavior for the ethanol-paired 
environment (Chacon & Luchiari, 2014).  It has also been found that one week of 
conditioning with 1.00 % ethanol significantly increased place preference in comparison 
to 1 day (i.e., acute) and 3 weeks of conditioning with 1.00% ethanol significantly 
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increased place preference relative to both 1 day and 1 week of conditioning (Parmar et 
al., 2011).  Due to such findings, it is unlikely that the overall lack of a CPP response in 
zebrafish chronically treated with ethanol is the result of pharmacologically impaired 
learning. Similar to acute ethanol findings in apparatus 2, the overall lack of observed 
effect in the present study may be attributable to reduced environmental distinction and 
overall low sample sizes (i.e., n = 6-8).     
The behavioral and pharmacological responses of animals to alcohol (i.e., 
ethanol), such as sensitivity, tolerance, and dependence, is known to be influenced by the 
genetic make-up of the organism (Crabbe, Belknap, & Buck, 1994).  In zebrafish, 
genetic-strain dependent behavioral differences in startle responses, social interactions, 
and tolerance have been observed following chronic ethanol exposure, albeit brain 
alcohol levels were comparable among strains (Dlugos & Rabin, 2003).  The fact that the 
responses of zebrafish to chronic ethanol in the present study do not reflect those that 
have been reported by other researchers may be due to differential genetic compositions 
of zebrafish.  In this regard, future investigation into the involvement of genotype in 
regulating the rewarding effects of ethanol is warranted.   
In addition to ethanol, CPP behavior in zebrafish following acute and chronic 
caffeine administration was investigated.  In the present study, in both apparatus designs, 
acute caffeine was not found to significantly increase time spent in the drug-paired side, 
and no statistically significant differences were revealed from between-subjects 
comparisons of difference scores. In rodents, a single (i.e., acute) intraperitoneal injection 
of caffeine at 0.8 mg/kg, 3 mg/kg, and 6 mg/kg did not induce CPP, although 1.5 mg/kg 
administration did produce CPP (Patkina & Zvartau, 1998).  Thus, evaluating rewarding 
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effects of acute caffeine in zebrafish will require further investigation and a broader range 
of doses to be evaluated. To date, there are no reports that caffeine can cross the blood-
brain barrier in zebrafish.  However, caffeine is observed to alter behavioral and 
endocrine phenotypes and is thus inferred that it has entered the brain and systemic 
circulation.  Another possible explanation for the overall, non-rewarding effects of acute 
caffeine that have been reported in the present study is that acute caffeine may increase 
anxiety-like behaviors in zebrafish (El Yacoubi, Ledent, Parmentier, Costentin, & 
Vaugeois, 2000; Sawyer, Julia, & Turin, 1982).    
Behavioral paradigms, such as the novel tank test, act as models of zebrafish 
anxiety and capitalize on innate behavioral responses of zebrafish to primarily dive and 
spend time on the bottom the novel tank (geotaxis).  Immersion in 100 mg/L caffeine for 
15-mins reduced transitions to top and time spent in upper portions of the novel tank, and 
increased instances of erratic movements. (Egan et al. 2009).  Additionally, immersion in 
250 mg/L caffeine for 20-mins significantly increased circulating cortisol levels, 
increased latency to upper half, freezing bouts, freezing duration, and decreased average 
velocity and distance traveled in the novel tank, all of which are indicative phenotypes of 
anxiety in zebrafish. (Cachat et al., 2010; Wong et al., 2010).  Albeit CPP is not a 
measure of anxiety, any anxiety-like effects that are induced by acute caffeine could 
potentially interfere with the sensitivity of CPP to measure reward.  In future studies, it 
would be beneficial to investigate if acute caffeine does indeed increase anxiety-like 
behaviors in zebrafish at the doses tested in the present study.   
Clinical data supports the link between caffeine consumption and the 
development of dependence (i.e., addiction) (Anderson & Juliano, 2012; Juliano & 
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Griffiths, 2004; Striley, Griffiths, & Cottler, 2011). In humans, caffeine is typically 
consumed over long (e.g., chronic) periods of time. When zebrafish were administered 
caffeine chronically a significant increase in place preference was found following 
treatment with 50 mg/L, but not at higher, potentially anxiogenic doses. The primary 
mechanism of caffeine in the brain is non-selective antagonism of adenosine receptors, 
the main targets being A1 and A2A adenosine receptor subtypes (Fredholm, Bättig, 
Holmén, Nehlig, & Zvartau, 1999; Nehlig, 1999).  The adenosinergic system of cyprinid 
fish is similar to that of mammals (Maximino et al., 2011), and zebrafish have been found 
to express A1, A2A1, A2A2 and A2B receptor subtypes 24 hours post-fertilization, the 
mRNA expression of which has been found to be modulated by caffeine exposure 
(Capiotti et al., 2011b). Adenosine is known to be a neuromodulator of dopamine 
transmission in the CNS (Cauli & Morelli, 2005).  Specifically, stimulation of adenosine 
A2 receptors by adenosine agonists has been found to decrease affinity of dopamine D2 
receptors for dopamine in humans and rodents (Ferre, von Euler, Johansson, Fredholm, & 
Fuxe, 1991).  Conversely, the antagonistic action of caffeine at A2 receptors inhibits the 
negative modulatory effects of adenosine on dopamine, and results in a potentiation of 
dopaminergic neurotransmission (Ferré, Fuxe, von Euler, Johansson, & Fredholm, 1992; 
Garrett & Griffiths, 1997; Nehlig, 1999; Pollack & Fink, 1995).  The dopaminergic 
system is highly conserved in zebrafish, the activation of which may underlie the 
rewarding effects of caffeine (Rink & Wullimann, 2002a, 2002b).  Collectively, this 
suggests that the rewarding effects of chronic caffeine treatment may be mediated by 
long-term antagonism of adenosine receptors and the association indirect dopamine 
transmission.   
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Lastly, the rewarding effects of acute and chronic nicotine were evaluated in this 
study, albeit only in apparatus design 2.  In the acute cohort, zebrafish in the control 
group displayed a significant increase in time spent in their non-preferred side, an effect 
that was not observed in zebrafish after receiving any dose of nicotine, and no between-
group differences in change in preference were found. The significant change in the acute 
control group was likely due to chance, as evidenced by a small change in place 
preference (i.e., a 3% increase). Zebrafish chronically administered nicotine did not 
display an increase in time spent in their non-preferred side following conditioning and 
there were no differences between-groups.  Zebrafish that were chronically administered 
10 mg/L nicotine spent significantly more time in the nicotine-paired side than zebrafish 
who received acute 10 mg/L of nicotine. 
In the literature, nicotine has been reported to induce CPP behavior in zebrafish at 
several doses and durations of exposure.  A single administration (i.e., acute) of 3, 30, 60, 
and 300 µmol 1-1 were all found to significantly increase place preference towards the 
drug-paired environment after conditioning (Kily et al., 2008).  The greatest effect was 
observed in animals who received 30 µmol 1-1 of nicotine, which spent 70% more time in 
the nicotine paired environment after conditioning in relation to before conditioning.  
Zebrafish were also found to demonstrate CPP following 21 days of abstinence after 
receiving 30 µmol 1-1 of nicotine.  Three conditioning sessions with a 300 µmol 1-1 of 
nicotine significantly decreased place preference, suggesting conditioned place aversion 
(CPA).  In a separate study a biased apparatus was employed, in that 20 minute exposure 
to 15 mg/L, 30 mg/L and 50 mg/L of nicotine was paired with an environment zebrafish 
experienced as innately aversive (Kedikian et al., 2013).  Despite this, zebrafish became 
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conditioned to spend significantly more time in the aversive environment following 
exposure to all concentrations of nicotine.  The reason for the overall lack of a CPP 
response to acute and chronic nicotine in the present study and the differential results 
from what has been reported in the literature is unclear. This may be due to genetic 
variability of zebrafish, differences in apparatus designs, and/or differences in sample 
sizes, and future investigation is warranted.     
Potential bias towards one environment over the other was evaluated in both 
apparatus designs.  An unbiased apparatus allows for a better detection of rewarding or 
aversive properties and has been held in higher regard than the biased design, as 
previously discussed (Sanchis-segura & Spanagel, 2006).  In apparatus design 1, 
significantly more zebrafish displayed a baseline side preference for the white side (n = 
75) than the dotted side (n = 48). However, zebrafish spent a comparable amount of time 
in their preferred side (i.e. white or dotted) during baseline preference testing. The 
experimenter was concerned that these results indicated a degree of side bias, and decided 
to create another apparatus design with comparable features of each environment, but 
distinct enough for zebrafish to discriminate between the two sides.  Side bias was not 
found to be present in zebrafish tested in apparatus design 2, and zebrafish spent a similar 
amount of time in their preferred side during baseline testing. Thus, apparatus 2 is 
inferred to be unbiased, in that zebrafish do not display a significant preference for one 
environment over the other.   
Lastly, the effect of conditioning order the change in place preference was 
assessed.  Zebrafish were conditioned in a counter-balanced order, in that half of the 
animals first received drug on their non-preferred side and received water on their 
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preferred side, and the other half of animals first received water on their preferred side 
and drug on their non-preferred side secondly.  Zebrafish that received drug second 
displayed a significantly greater change in place preference than fish that received drug 
first.  In this latter group, it is likely that the drug is still present in the zebrafish CNS 
when it is placed into the preferred side second and is given water, after having 
previously received drug.  Pilot studies are currently being conducted in which 
conditioning is carried out over a period of two days instead of one to avoid such a 
carryover effect.                
Limitations 
There are, however, notable limitations of the zebrafish model of drug reward.  
One such issue pertains to methods of drug delivery.  The most commonly employed 
method of administration is via submersion in a bath solution containing a concentration 
of the drug to be absorbed by the gills, skin, and mouth.  Zebrafish are known to absorb 
most water-soluble drugs administered in this manner, but the degree of uptake can vary 
among individuals (Best & Alderton, 2008).  Conducting preliminary studies to confirm 
that rates of absorption reflect drug concentration in the water may circumvent this issue.  
Behavioral paradigms employed in addiction research have only recently been adopted in 
zebrafish research, and there is thus a lack of information available regarding drug 
absorption and metabolism rates (Klee, Ebbert, Schneider, Hurt, & Ekker, 2011).  It is 
possible that the effects of alcohol, nicotine and caffeine may have been influenced by 
the bioavailability of each substance in the CNS of the zebrafish.  Another method of 
drug administration in zebrafish is intraperitoneal injection, which has been reported to 
be a more precise method of drug delivery (Kinkel, Eames, Philipson, & Prince, 2010), 
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although injections will reduce the rate of throughput and may be a stressful procedure 
for animals.   
Furthermore, although zebrafish have similar CNS structure to humans and 
possess all the major mammalian neurotransmitters, there are undoubtedly very large 
differences in animal physiology.  For instance, two forms of the serotonin transporter, 
SERT A and B, are found in zebrafish and not in mammals or humans (Norton, Folchert, 
& Bally-Cuif, 2008; Wang, Takai, Yoshioka, & Shirabe, 2006).  Moreover, as there are 
notable differences in neuronal architecture, the underlying mechanisms and brain 
structures associated with reward learning are likely to differ to some degree (Eddins, 
Petro, Williams, Cerutti, & Levin, 2009). Experimental subjects used in this study were 
of a randomly bred genetically heterogeneous background referred to as wildtype.  
Testing various strains and mutant fish in the CPP paradigm would help shed light on 
how drug reward is mediated by genetic makeup (Klee et al., 2012; Ninkovic & Bally-
Cuif, 2006).  Another limitation of the present study is low sample sizes, particularly of 
zebrafish tested in apparatus 2, most notably those that received chronic treatment, which 
may have reduced the power to detect a true treatment effect.  Increasing sample sizes in 
a number of groups may thus be warranted, and will be carried out in future studies. As 
previously mentioned, apparatus 2 was designed to eliminate side bias by creating 
environments that were similar, in that they both possessed blue shapes of the same 
quantity, but different in pattern and shape. It may be that zebrafish were not able to 
differentiate between these two environments very well, potentially impacting the ability 
of these animals to form a strong conditioned association and a CPP response. Future 
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studies will be carried out with apparatus designs with a greater degree of environmental 
distinction, whilst avoiding the creation of a side bias.  
Conclusion 
Overall, zebrafish are an excellent animal model for studying human brain 
disorders, due to an ideal balance of simplicity and complexity in both anatomy and 
behavior.  Conditioned place preference models of drug reward will help illuminate 
processes and mechanisms underlying the rewarding effects of drugs.  Information 
garnered from zebrafish in this regard, can indicate appropriate avenues of research that 
would benefit from further investigation in mammalian models, and ultimately, humans.       
In summary, zebrafish are an excellent model to study the rewarding effects of both well-
classified and novel compounds in a relatively medium to high-throughput manner.  This 
claim is supported by conditioned place preference behavior reported in zebrafish 
following administration of a wide range psychoactive substances that mirror mammalian 
CPP findings (Lau et al., 2006; Ninkovic et al., 2006; Braida et al., 2007; Kily et al., 
2008; Mathur et al., 2011a; Darland et al., 2012), including those reported here.  
Information garnered from this study provides further support that the marriage of CPP 
and zebrafish is a viable model of drug reward, and is sensitive to three frequently used 
substances, alcohol, caffeine and nicotine.  The zebrafish CPP model has intrinsic 
translational value, and is well-suited for future studies of pharmacological, 
environmental, and genetic manipulation, which will likely increase understanding of 
factors contributing to the pathogenesis of addiction and subsequently aid in the develop 
of treatment and prevention strategies that will contribute to the reduction of human 
suffering.   
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